Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00533468 · ClinicalTrials.gov registry record · Phase 4
"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."
A Phase 4 study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00533468 is a Phase 4 study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 70 participants.
The verdict
NCT00533468, a Phase 4 study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The study's hypothesis is LMX4 cream, a topical anesthetic cream, will reduce the pain of infants undergoing Lumbar Puncture (spinal tap).
Interventions
- DRUG Placebo
- DRUG Lidocaine Cream 4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00533468
The ClinicalTrials.gov registry entry for NCT00533468 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00533468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00533468 about?
NCT00533468 is a clinical study titled ""Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."". The study's hypothesis is LMX4 cream, a topical anesthetic cream, will reduce the pain of infants undergoing Lumbar Puncture (spinal tap).
What is the current status of trial NCT00533468?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2007-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00533468?
The interventions under investigation include: Placebo (DRUG), Lidocaine Cream 4% (DRUG).
Who is sponsoring clinical trial NCT00533468?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.